Cure My Disease

Don't miss your cure!

 Log in / Sign up

Brain function in Friedreich's ataxia: new clues from genetic testing

NCT ID NCT05874388

Ongoing Knowledge-focused Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Source: ClinicalTrials.gov ↗

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study looks at how Friedreich's ataxia, a genetic nerve disease, affects thinking skills like memory and problem-solving. Researchers will compare cognitive test results between people with the condition and healthy volunteers, and see if these results relate to the number of genetic repeats in the FXN gene. The goal is to better understand the cognitive challenges patients face.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could help predict cognitive decline in Friedreich's ataxia and guide personalized care.
What could go wrong
This is an observational study with no treatment, so it cannot directly improve outcomes. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FRIEDREICH ATAXIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Friedreich ataxia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FRIEDREICH ATAXIA

Contacts and locations

Locations

  • Hôpital Necker-Enfants Malades

    Paris, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.